FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106351 [Registered on: 17/03/2026] Trial Registered Prospectively
Last Modified On: 16/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   Predicting kidney and liver injury following heart surgery using an ultrasound based scoring system done before surgery in patients with heart disease. 
Scientific Title of Study   Venous excess ultrasound score in mitral valve disease patients undergoing mitral valve surgery and risk of post-operative kidney and liver injury: A prospective observational study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shindhujaa A D 
Designation  Junior resident 
Affiliation  Jawaharlal institute of postgraduate medical education and research 
Address  Department of Anaesthesiology and Critical Care, Jawaharlal institute of postgraduate medical education and research, JIPMER campus road, dhanvantari nagar, Gorimedu, Puducherry

Pondicherry
PONDICHERRY
605006
India 
Phone  9655999113  
Fax    
Email  aditi.dn19@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Satyen Parida 
Designation  Professor and HOD 
Affiliation  Jawaharlal institute of postgraduate medical education and research 
Address  Department of Anaesthesiology and Critical Care, Jawaharlal institute of postgraduate medical education and research, JIPMER campus road, dhanvantari nagar, Gorimedu, Puducherry

Pondicherry
PONDICHERRY
605006
India 
Phone  7708746042  
Fax    
Email  jipmersatyen@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shindhujaa A D 
Designation  Junior resident 
Affiliation  Jawaharlal institute of postgraduate medical education and research 
Address  Department of Anaesthesiology and Critical Care, Jawaharlal institute of postgraduate medical education and research, JIPMER campus road, dhanvantari nagar, Gorimedu, Puducherry

Pondicherry
PONDICHERRY
605006
India 
Phone  9655999113  
Fax    
Email  aditi.dn19@gmail.com  
 
Source of Monetary or Material Support  
Jawaharlal institute of postgraduate medical education and research Puducherry 
 
Primary Sponsor  
Name  Jawaharlal institute of postgraduate medical education and research 
Address  JIPMER campus road, dhanvantari nagar, Gorimedu, Puducherry 605006 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrShindhujaa A D  Jawaharlal institute of postgraduate medical education and research  Department of Anaesthesiology and Critical care, Institute block second floor, JIPMER campus, Dhanvantari nagar, Gorimedu, Puducherry 605006
Pondicherry
PONDICHERRY 
9655999113

aditi.dn19@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE FOR OBSERVATIONAL STUDIES, JIPMER  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I340||Nonrheumatic mitral (valve) insufficiency, (2) ICD-10 Condition: I342||Nonrheumatic mitral (valve) stenosis, (3) ICD-10 Condition: I051||Rheumatic mitral insufficiency, (4) ICD-10 Condition: I050||Rheumatic mitral stenosis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL   NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Adults undergoing elective mitral valve surgery 
 
ExclusionCriteria 
Details  Patients already receiving mechanical ventilation
Patients already receiving ionotropes
Emergency surgery
Pregnancy
Chronic liver and kidney disease
IVC thrombus
Combined CABG and mitral valve surgery 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To compare the incidence of acute kidney injury and liver dysfunction in patients with mitral valve disease undergoing mitral valve surgery and VExUS score more than or equal to 1 with VExUS equal to zero  Patient will be followed up until the patient is admitted in the post-operative ward or till POD-7
All patients enrolled in the study will be further followed up in OPDs and if not will be followed up with a telephone call at 30 and 60 days after the hospital discharge 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the utility of BNP as risk predictor of composite of kidney and liver dysfunction after mitral valve surgery
To stratify the incidence of composite of kidney and liver dysfunction based on the grading of VExUS score
To evaluate the correlation between VExUS score and BNP
To identify correlation between individual component of VExUS and kidney and liver dysfunction  
 
  BNP evaluation is done before anaesthetic induction.
Patient will be followed up until the patient is admitted in the post-operative ward or till POD-7
All patients enrolled in the study will be further followed up in OPDs and if not will be followed up with a telephone call at 30 and 60 days after the hospital discharge. 
 
Target Sample Size   Total Sample Size="62"
Sample Size from India="62" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Recruitment of the patients will be done after the completion of CTRI registration. Patients satisfying the eligibility criteria will be included in the study after obtaining written informed consent. Before anaesthetic induction 2ml of venous blood sample will be obtained for BNP evaluation. Transthoracic echocardiographic examination and ultrasound scanning of liver and kidney will also be done before anaesthetic induction. Induction choice and insertion of pulmonary artery catheter will be based on the discretion of attending anaesthesiologist. Assessment of venous congestion will be performed using doppler based techniques. maximum size of IVC will be measured at the level of drainage of hepatic veins into IVC. Patients with IVC size of more than 2cms will be considered as having venous congestion and the patient will undergo further scanning of hepatic vein, portal vein and renal vein to quantify the intra-abdominal venous congestion. Those with IVC size less than 2cms will be labelled as VExUS score of 0 and no further scanning will be performed. Corresponding to the level of venous congestion VExUS score will be obtained. The primary outcome will be the composite of kidney and liver dysfunction. Acute kidney injury will be defined by the KDIGO criteria and acute liver injury will be defined as postoperative 1.5 times rise in ALT/AST/GGT during any time of index hospitalisation after cardiac surgery. Data concerning the performed procedure will be collected including duration of surgery, total fluid administration, duration of cardiopulmonary bypass, duration of cross-clamp time, urine output, blood loss, blood transfusion and vasoactive inotropic score will be obtained. The duration of mechanical ventilation, ICU stay, length of hospital stay and other major organ complications ( cardiovascular and neurological ) including mortality will be recorded during the hospital stay. All patients enrolled in the study will be further followed up in OPDs and if not will be followed up with a telephone call at 30 and 60 days after the hospital discharge to assess the rate of re-hospitalisation and death. 
Close